PatientsVille.com Logo

LOSS OF CONSCIOUSNESS and Xanax

PatientsVille

LOSS OF CONSCIOUSNESS Symptoms and Causes

Reye syndrome is a rare illness that can affect the blood, liver, and brain of someone who has recently had a viral infection. It always follows another illness. Although it mostly affects children and teens, anyone can get it. It can develop quickly and without warning. It is most common during flu season. Symptoms include

  • Nausea and vomiting
  • Listlessness
  • Personality change - such as irritability, combativeness or confusion
  • Delirium
  • Convulsions
  • Loss of consciousness

If these symptoms occur soon after a viral illness, seek medical attention immediately. Reye syndrome can lead to a coma and brain death, so quick diagnosis and treatment are critical. Treatment focuses on preventing brain damage. There is no cure.

The cause of Reye syndrome is unknown. Studies have shown that taking aspirin increases the risk of getting it. Because of that, health care professionals now recommend other pain relievers for young patients.

NIH: National Institute of Neurological Disorders and Stroke

Check out the latest treatments for LOSS OF CONSCIOUSNESS

LOSS OF CONSCIOUSNESS treatment research studies

Xanax clinical trials, surveys and public health registries


Find Drug Side Effect reports



Xanax Side Effects

Anxiety (349)
Insomnia (242)
Depression (220)
Feeling Abnormal (204)
Somnolence (198)
Nausea (194)
Headache (190)
Malaise (176)
Fatigue (172)
Fall (171)
Overdose (159)
Dizziness (157)
Pain (153)
Dyspnoea (145)
Suicide Attempt (143)
Diarrhoea (142)
Hypertension (136)
Confusional State (131)
Convulsion (129)
Agitation (122)
Tremor (83)
Loss Of Consciousness (75)
Sopor (74)
Intentional Overdose (73)
Amnesia (72)
Panic Attack (68)
Nervousness (64)
Back Pain (64)
Chest Pain (61)
Withdrawal Syndrome (61)
Off Label Use (60)
Suicidal Ideation (60)
Weight Increased (60)
Weight Decreased (59)
Blood Pressure Increased (58)
Vomiting (58)
Asthenia (56)
Blood Cholesterol Increased (55)
Death (53)
Road Traffic Accident (52)
Myocardial Infarction (51)
Pruritus (51)
Abdominal Pain Upper (51)
Rash (49)
Aggression (48)
Abnormal Behaviour (47)
Hypotension (46)
Decreased Appetite (46)
Oedema Peripheral (45)
Hallucination (45)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

Breast pain

How long dose xanax stays in your system

I have xanax 0.25 mg im scared to take them

I took Mucinex DM 1200mg once at 10:30 pm and again at 10:30 am. By noon I wasnt functional at all, I had severe loss of focus, my eyes were dilated, and I was really slow, on top of the usual side effects of being jittery and nauseous. Since

I have been put on Molipaxin 3 weeks ago, I have dry mouth, hair loss and my panic attacks were showing no signs of improvement. Dr increased it to 100mg and put me onto Lamictin. I am not bi polar nor epileptic. My disorder ist algora phoebia. I a

leg cramps, hair loss Would it be better to take Lisinopril?

Have taken hydrea for a year because my spleen had increased in size. I have noticed increased loss of memory and some confusion for the past couple of months. I take 500 mg every other day and 1000 mg every other day.

I am having cramps, muscle pain, memory loss, I have been on Revlmid for about 1 year. Does anybody else my age have this disease, I am only 46 yr woman.

I have experienced weight loss of a pound a month for the last 2 years, since taking 100 mcg per day. My dr. can find no cause for this loss. I also have taken Metformin for about the same amount of time.

I have seen a significant loss of hair after about three months. I went to my dermatologist and told her that I feel that it is from Solodyn and she sent me to have blood work done thinking I may be anemic or I have a thyroid problem.

Anon- I would say the weed would cause the MOST memory loss used over time also depending on how strong it is ie, (haze, kush....dro...regs from 60's with seeds) THE STONGER it is the faster the brain cells go! As far as the valium/dia

<strong>Found Celepram effective at the end of the 3rd week. Effectiveness lasted for around 14 days. Following period i experienced continualled short term memory loss, hallucinations of seeing stars, skin irritated rash, shortness of breath &

3 months child red all over, staring, screaming high pitched cry, tracking red lines from injection site, lowered consciousness, screaming for more than 2 hours worse upon lying down. Would not breastfeed for 8 hours. Dosed exhuasted and awoke with h

LOSS OF CONSCIOUSNESS Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Bioequivalence Of A Test Alprazolam Sublingual Formulation Compared To A Commercial Sublingual Formulation
Condition: Healthy
Interventions: Drug: alprazolam sublingual tablet commercial;   Drug: alprazolam sublingual tablet test
Outcome Measures: Alprazolam bioavailability assessed as area under the concentration-time curve (AUC) and maximum concentration (Cmax);   Alprazolam time of maximum concentration (Tmax) and half life;   Adverse events, clinical laboratory tests, vital signs
2 Recruiting Imaging the Effects of Zolpidem and Alprazolam in Healthy Volunteers at 3T
Condition: Psychotropic Drugs Effects
Interventions: Drug: Zolpidem;   Drug: Alprazolam;   Drug: Caffeine;   Other: Placebo
Outcome Measures: Change in blood oxygen level-dependent (BOLD) signal as measured with fMRI;   Change in subjective drug effects as measured by self-report questionnaires
3 Unknown  Drug Treatment Validation of Functional Magnetic Resonance Imaging in Generalized Anxiety Disorder
Condition: Generalized Anxiety Disorder
Interventions: Drug: Alprazolam (Xanax);   Drug: Placebo
Outcome Measures: To evaluate the effect of an anxiolytic drug versus placebo on brain activity at rest and during emotional stimuli using fMRI.;   To evaluate the effects of an anxiolytic drug versus placebo on eye blink startle response at rest and during emotional stimuli (anxiety potentiated startle, APS) as well as on clinical scales.;   To correlate the fMRI measurements with the clinical/behavioral measurements of efficacy.
4 Unknown  Effects of Buspar on Depressive Symptom Improvement and Neuroprotection in Patients With Anxiety Disorder
Condition: Anxiety Disorder
Interventions: Drug: buspirone+alprazolam;   Drug: alprazolam;   Other: healthy controls
Outcome Measures: change from baseline in depressive symptom scores at 8 weeks;   change from baseline in depressive symptom scores at 4 weeks;   change from baseline in depressive symptom scores at 1 week;   change from baseline in anxiety symptom scores at 8 weeks;   change from baseline in anxiety symptom scores at 4 weeks;   change from baseline in anxiety symptom scores at 1 week;   changes from baseline in brain structure, function, and biochemical metabolism, analyzed using the computational approach;   number of participants with adverse events
5 Recruiting Gabapentin Treatment of Benzodiazepine Dependence
Condition: Benzodiazepine Dependence
Interventions: Drug: gabapentin;   Drug: Placebo
Outcome Measure: Abstinence from Benzodiazepine use
6 Recruiting Effects of a CRF1 Receptor Antagonist on Human Startle in Normal Female Volunteers
Condition: Anxiety Disorders
Intervention:
Outcome Measure:
7 Recruiting Influence of Anesthesia Technique on Postoperative Evolution After Urogenital Surgical Interventions
Conditions: Anesthesia; Reaction;   Adverse Effect of Other General Anesthetics;   Adverse Anesthesia Outcome;   Acute Kidney Injury
Interventions: Procedure: epidural catheter insertion;   Procedure: robot assisted laparoscopic urogenital surgery
Outcome Measures: acute kidney injury;   postoperative outcome
8 Recruiting Effects of Hallucinogens and Other Drugs on Mood and Performance
Condition: Healthy
Intervention: Drug: Hallucinogens and psychoactive substances
Outcome Measures: Rating of "Drug Liking" on the End of Day Questionnaire;   Hallucinogen Rating Scale